Tenor Capital Management Co., L.P. Ironwood Pharmaceuticals Inc Transaction History
Tenor Capital Management Co., L.P.
- $35.7 Million
- Q1 2024
A detailed history of Tenor Capital Management Co., L.P. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Tenor Capital Management Co., L.P. holds 208,200 shares of IRWD stock, worth $1.31 Million. This represents 5.08% of its overall portfolio holdings.
Number of Shares
208,200Holding current value
$1.31 Million% of portfolio
5.08%Shares
1 transactions
Others Institutions Holding IRWD
# of Institutions
296Shares Held
170MCall Options Held
27.1MPut Options Held
2.28M-
Black Rock Inc. New York, NY24.2MShares$152 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$123 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$103 Million24.97% of portfolio
-
State Street Corp Boston, MA13.9MShares$87.7 Million0.01% of portfolio
-
Pacer Advisors, Inc. Malvern, PA7.21MShares$45.4 Million0.16% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $965M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...